Flexera Named a 2017 Top Workplace by the Chicago Tribune
Nov 21, 2017 13:01 pm UTC| Business
ITASCA, Ill., Nov. 21, 2017 -- Flexera, the company that’s reimagining how software is bought, sold, managed and secured, today announced it’s been awarded a 2017 Top Workplaces honor by The Chicago Tribune for the...
TESARO Secures $500 Million Non-Dilutive Term Loan Financing
Nov 21, 2017 13:01 pm UTC| Business
WALTHAM, Mass., Nov. 21, 2017 -- TESARO, Inc. (NASDAQ:TSRO), an oncology focused biopharmaceutical company, announced today that it has entered into a definitive term loan agreement with BIOPHARMA CREDIT PLC and...
Invuity to Present at Piper Jaffray Healthcare Conference
Nov 21, 2017 13:01 pm UTC| Business
SAN FRANCISCO, Nov. 21, 2017 -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced that company management is scheduled to present at the 29th Annual...
Menlo Therapeutics Begins Phase 2 Clinical Trial for Pruritus Associated with Psoriasis
Nov 21, 2017 13:01 pm UTC| Business
REDWOOD CITY, Calif., Nov. 21, 2017 -- Menlo Therapeutics Inc., a late-stage biopharmaceutical company developing a neurokinin 1 (NK‐1) receptor antagonist (serlopitant) for the treatment of pruritus (itch) and...
Qorvo® Scheduled to Present at Upcoming November and December 2017 Investor Presentations
Nov 21, 2017 13:01 pm UTC| Business
GREENSBORO, N.C., Nov. 21, 2017 -- Qorvo® (Nasdaq:QRVO), a leading provider of innovative RF solutions that connect the world, today announced that Company executives are scheduled to present at two upcoming investor...
Nov 21, 2017 13:01 pm UTC| Business
Auris Medical to Report Third Quarter 2017 Financial Results and Provide Business Update on Tuesday, November 28, 2017 Zug, Switzerland, November 21, 2017 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage...
Fate Therapeutics to Present at the 2017 Piper Jaffray Healthcare Conference
Nov 21, 2017 13:00 pm UTC| Business
SAN DIEGO, Nov. 21, 2017 -- Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders,...
The “Takaichi Trade”: How Japan’s First Female PM Is Shaping the Yen
How the US–India tariff truce boosts major Indian industries, Surat to Pharma